We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Up to 30% of people infected with SARS-CoV-2 report disabling symptoms 2 years after the infection. Over 100 persistent symptoms have been associated with Post-Acute COVID-19 Symptoms (PACS) and/or long-COVID, showing a significant clinical heterogeneity. To develop effective, patient-targeted treatment, a better understanding of underlying mechanisms is needed. Epigenetics has helped elucidating the pathophysiology of several health conditions and it might help unravelling inter-individual differences in patients with PACS and long-COVID. As accumulating research is exploring epigenetic mechanisms in PACS and long-COVID, we systematically summarized the available literature on the topic.
Methods
We interrogated five databases (Medline, Embase, Web of Science, Scopus and medXriv/bioXriv) and followed PRISMA and SWiM guidelines to report our results.
Results
Eight studies were included in our review. Six studies explored DNA methylation in PACS and/or long-COVID, while two studies explored miRNA expression in long-COVID associated with lung complications. Sample sizes were mostly small and study quality was low or fair. The main limitation of the included studies was a poor characterization of the patient population that made a homogeneous synthesis of the literature challenging. However, studies on DNA methylation showed that mechanisms related to the immune and the autonomic nervous system, and cell metabolism might be implicated in the pathophysiology of PACS and long-COVID.
Conclusion
Epigenetic changes might help elucidating PACS and long-COVID underlying mechanisms, aid subgrouping, and point towards tailored treatments. Preliminary evidence is promising but scarce. Biological and epigenetic research on long-COVID will benefit millions of people suffering from long-COVID and has the potential to be transferable and benefit other conditions as well, such as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). We urge future research to employ longitudinal designs and provide a better characterization of included patients.
Recent development in immunotherapy for cancer treatment has substantiated to be more effective than most of the other treatments. Immunity is the first line of defence of the body; nevertheless, cancerous cells can manipulate immunity compartments to play several roles in tumour progression. Tumour-associated macrophages (TAMs), one of the most dominant components in the tumour microenvironment, are recognized as anti-tumour suppressors. Unfortunately, the complete behaviour of TAMs is still unclear and understudied. TAM density is directly correlated with the progression and poor prognosis of hepatocellular carcinoma (HCC), therefore studying TAMs from different points of view passing by all the factors that may affect its existence, polarization, functions and repolarization are of great importance. Different epigenetic regulations were reported to have a direct relation with both HCC and TAMs. Here, this review discusses different epigenetic regulations that can affect TAMs in HCC whether positively or negatively.
Although resilient youth provide an important model of successful adaptation to adversity, we know relatively little about the origins of their positive outcomes, particularly the role of biological mechanisms. The current study employed a series of methylome-wide association studies to identify methylomic biomarkers of resilience in a unique sample of 276 twins within 141 families residing in disadvantaged neighborhoods. Results revealed methylome-wide significant differentially methylated probes (DMPs) for social and academic resilience and suggestive DMPs for psychological resilience and resilience across domains. Pathway analyses informed our understanding of the biological underpinnings of significant differentially methylated probes. Monozygotic twin difference analyses were then employed to narrow in on DMPs that were specifically environmental in origin. Our findings suggest that alterations in the DNA methylome may be implicated in youth resilience to neighborhood adversity and that some of the suggestive DMPs may be environmentally engendered. Importantly, our ability to replicate our findings in a well-powered sample was hindered by the scarcity of twin samples with youth exposed to moderate to substantial levels of adversity. Thus, although preliminary, the present study is the first to identify DNA methylation biomarkers of academic and social resilience.
This chapter investigates possible future directions of the DOHaD framework. Specifically, it discusses options to translate the framework into the Anthropocene. In a first step, I outline how recent research on epigenetics, the human microbiome, and planetary boundaries challenges notions of origin and development embedded in DOHaD research. I then outline three distinct modes of interdisciplinary collaboration: subordination–service, integration–synthesis, and agonistic–antagonistic. I discuss how each of these modes offers the possibility to conduct research across the nature–culture divide and address human bodies and environments as anthropogenic due to their complex natural, social, and political histories. I conclude that the DOHaD framework needs to embrace the idea of anthropogenic biology to address the challenges of the Anthropocene and take responsibility for the knowledge that it produces in an attempt to shape a politics of habitability for our planet.
In this introduction to the Handbook of DOHaD and Society, we provide an overview of the biosocial research field of the Developmental Origins of Health and Disease (DOHaD). We first trace the evolution of this interdisciplinary field over the past two decades, charting the historical conditions that have brought DOHaD to a critical moment when the field is at a threshold of interdisciplinary innovation across both life and social sciences. We then discuss the biosocial perspective that DOHaD offers as its central premise and promise, allowing for questions of socio-environmental justice, discrimination, and equity to be centred in science and biomedicine. We explore the challenges that complicate this biosocial agenda in practice and attend to questions of research translation, interdisciplinary collaboration, and the socio-cultural dimensions of DOHaD-based health interventions. We end by highlighting the transformational potential of the DOHaD research paradigm and how this handbook offers a toolkit for robust interdisciplinary research in this field.
Embodiment is a key concept in the social sciences and has been particularly useful in discussions of the body, health, and disease. Embodiment allows us to connect the subjective experiences of the body, as well as its lived materiality, to broader social contexts. The concept also helps researchers make sense of the ways in which the body is inscribed with history, politics, and culture. This chapter explores the concept of embodiment in the social sciences and its potential use in DOHaD. We argue that it is important to integrate concepts/tools from the social sciences, in this case embodiment, as biosocial collaborations compel cross-disciplinary legibility and a shared vocabulary. Moreover, this integration of concepts and tools would allow DOHaD as a field to deepen awareness and understanding of the kind of influence environmental experiences can have on the development of health and disease over the lifecourse. We suggest that this deeper awareness and understanding achieved through employing the embodiment concept can make DOHaD research and interventions more socially just and socially sensitive.
The term ‘intergenerational trauma’ describes how trauma experienced in one generation can reverberate in the lives of descendants. The concept has been variously defined in relation to other disciplines and has overlaps with cognate concepts, including historical trauma, transgenerational trauma, and post-traumatic stress disorder (PTSD). In this chapter, we provide a conceptual overview of intergenerational trauma in the interdisciplinary field of DOHaD research. Intergenerational trauma is of interest to many disciplines and frameworks in part because it lends itself to ’biosocial’ understandings of violence and discriminatory social contexts as physiologically embodied. Yet, intergenerational trauma also presents challenges for scientific study due to the difficulties inherent in stabilising it as a scientific object. Given the growing public interest in intergenerational trauma and its routinised clinical uptake for the care of marginalised communities, this chapter also considers a range of important questions related to policy translation, biopolitics, and social justice.
DOHaD research on preconception, prenatal, and early-life periods of human development can provide a critical resource for legal thinkers interrogating the lines of responsibility for environmental harms (both physical and psychosocial) that affect a child’s growth and development. DOHaD scholars who engage with epigenetic research offer an evidentiary narrative that traces the causal origin of early-life health harms to events that have occurred during pregnancy and prior to conception. Scientific research is increasingly providing evidence that those who suffer disadvantage throughout their lifecourse (in conditions of systemic oppression such as from racism, sexism, or poverty) may be disproportionately subject to molecular changes, creating harmed subgroups that are then intergenerationally reproduced as socially disadvantaged communities. Drawing examples from Australia, the United States, and Canada, this chapter asks what legal obligations, if any, should or can be imposed on contemporary society to ensure not just the future ’health’ of existing children (as they grow into adults) but also the generations of people yet to be born. It is argued that traditional common law legal responses that place responsibility on the individual rather than the community do not ensure intergenerational justice.
This chapter argues against the narrative that posits a pre-twentieth century past, where the mother and fetus were one, in contrast with the present, where the fetus is visible and autonomous. I complicate this narrative by showing that the maternal–fetal relationship was redrawn and reinterpreted multiple times in the twentieth century. The ‘fetal parasite’ era was informed by the hereditarianism of the early 1900s. The notion of a developing organism sensitive to external influences was replaced by a remarkably sheltered fetus. In contrast, concerns around the physical and psychological trauma following the Second World War supported the notion of ‘critical’ periods, responsive to external influences mediated by the mother. Yet soon thereafter, the language and imagery of an autonomous, self-sufficient fetus became prevalent amidst political battles over abortion. The notion of the autonomous fetus is linked to evolutionary biology’s 1970s concepts of the ‘selfish gene’ – with the ‘selfish’ fetus pitted against the mother in the struggle over scarce resources. By the 1990s, the rise of DOHaD and epigenetics signalled a return of the maternally mediated environment to the science of human development. While some interpreted this as a return to the pre-modern model, there is a significant difference. Here maternal experiences and surroundings have to be rendered accessible to an experimental, molecular approach and to show evidence of a quantifiable change in observed parameters.
Despite the promise of a post-racial science, debates over the meaning and implications of race and population differences have persisted, albeit in transformed terms. Given that they eschew fixed genetic differences, ‘biosocial’ perspectives on race have brought with them a renewed focus on the social, historical, and political bases of contemporary health disparities. However, the move away from reference to fixed genes in describing how racial health disparities emerge or are maintained is not without problems. In this chapter, we first challenge the notion that the embrace of environmentally driven effects is inherently progressive, through an examination of the longue durée of pre-modern racial typologies. Second, we review recent research within DOHaD and environmental epigenetics that addresses racial health disparities. Our review reflects our concern that postgenomics has the potential to catalyse new forms of essentialism and typological thinking. Studies in our review hew closely to essentialist forms of racial thought, albeit now marked by methylation differences and adverse early life conditions. To avoid the return of racialised typological thinking, we suggest methodological interventions and various research orientations, such as interdisciplinarity, that can prevent a return to notions of fixed racial difference
The environment represents a central research object in the Developmental Origins of Health and Disease (DOHaD) and related fields such as epigenetics. This chapter discusses how DOHaD researchers operationalise and measure environments in and through their research practices to produce knowledge on how environmental experiences relate to health outcomes over the lifecourse. While DOHaD researchers discursively acknowledge the complexity of lived environments, we identify some of the current challenges to put this complexity into research practice, often resulting in reductionist accounts of the dynamic nature of human experiences. By proposing the term ’doing environments,’ we emphasise how practices to enact environments for scientific inquiry are products of decisions and negotiation processes that need careful consideration on what social and political consequences these ’doings’ might have and for whom. To that end, we aim to lay the ground for interdisciplinary conversations to engage in critical reflections about the social and political dimensions of doing environments in DOHaD research.
DOHaD and epigenetic research that investigates causal mechanisms and predictive biomarkers has often occurred in the absence of discussion of ethical, legal, and social implications or engagement with disability communities. These implications include maternal blaming, labelling, stigmatisation, and ableism. Considering the debate on different models of disability by disability activists and social scientists, this is a timely opportunity to optimise the design of epigenetic research into conditions labelled as disabilities. Research aims should address the needs of disability communities, acknowledge diversity, and move away from medical to social models of disability. Here we focus on the autistic community as an example. We argue that there is a need to work with autistic people and their supporters to co-design studies that facilitate a better understanding of autism’s challenges and assets and to use this knowledge to assist these individuals and communities. We also stress the importance of autonomy and information provision in relation to autistic individuals’ engagement with epigenetics tests. We conclude by urging researchers planning DOHaD and epigenetics research to listen to and engage with disability communities when they say, ‘nothing about us without us’.
Take a journey into the fascinating world of microRNA, the genome's master controllers. Discovered in 1993, our genome's master controllers are critical to the evolution of complex life, including humans. This captivating book tells their story, from their discovery and unique role in regulating protein levels to their practical applications in brain health and other branches of medicine. Written by a neuroscientist, it provides an in-depth look at what we know about microRNAs and how we came to know it. Explore the impact of these molecular conductors on your life and gain a new appreciation for the precision they bring to the molecular noise in our cells. Perfect for students of neuroscience, life sciences such as biochemistry and genetics and the curious public alike, this is the captivating tale of the conductors of life's molecular orchestra.
The innate immune response is the host’s first line of defense, promptly activated upon pathogen invasion. Its precise and rapid activation relies on innate immune cells (IICs). Upon recognizing danger signals postinfection or injury, they release various innate immune effectors to eliminate invading pathogens or damaged cells, thus supporting the host’s immune homeostasis. Epigenetic modifications, by shaping chromatin structures, orchestrate specific gene transcription patterns to regulate the lineage development, differentiation, and activation of IICs. This intricate process ultimately contributes to effective pathogen clearance and IICs’ healthy development and differentiation. To thoroughly elucidate the epigenetic mechanisms underlying the development and differentiation of IICs, this review first introduces the fundamental concepts and latest advancements in this field. We then delve into how the immune microenvironment or other signaling molecules shape the epigenetic landscapes of distinct IIC subsets during their lineage development and differentiation. Furthermore, we summarize how different epigenetic modification profiles mediate specific transcriptional patterns, thereby influencing the lineage development, differentiation, and activation of IICs in response to infections or injuries. Finally, we discuss several unresolved critical issues from the perspective of targeting epigenetic modifications to modulate the innate immune response. In summary, this review aims to uncover the molecular mechanisms underlying the development, differentiation, and activation of IICs from an epigenetic perspective, providing theoretical foundations for scientific and medical researchers pursuing disease treatments.
Edited by
Allan Young, Institute of Psychiatry, King's College London,Marsal Sanches, Baylor College of Medicine, Texas,Jair C. Soares, McGovern Medical School, The University of Texas,Mario Juruena, King's College London
Mood disorders, including bipolar disorder (BD) and major depressive disorder (MDD), are known to have a significant genetic component based on familial and twin studies. Tremendous efforts from the scientific community and technical advancements have led to the discovery of multiple genes associated with the heritability of these disorders over the last years. Nonetheless, our knowledge of the exact genetic basis of BD and MDD is still fairly limited. Recent genome-wide association studies with massive sample sizes have started to characterize the polygenicity of these disorders, although future studies have yet to explore how genetic variants may interact with the environment to modulate one’s risk of disease. As our understanding of the genetics of mood disorders increases (with increasing sample sizes, a more significant shift from candidate gene studies to microarray and sequencing strategies, and integration of findings with environmental measures), many clinical opportunities may arise. This may include the future use of polygenic risk scores for risk assessment, predicting response to medications based on genotype, among others.
Childhood obesity represents a significant global health concern and identifying its risk factors is crucial for developing intervention programs. Many “omics” factors associated with the risk of developing obesity have been identified, including genomic, microbiomic, and epigenomic factors. Here, using a sample of 48 infants, we investigated how the methylation profiles in cord blood and placenta at birth were associated with weight outcomes (specifically, conditional weight gain, body mass index, and weight-for-length ratio) at age six months. We characterized genome-wide DNA methylation profiles using the Illumina Infinium MethylationEpic chip, and incorporated information on child and maternal health, and various environmental factors into the analysis. We used regression analysis to identify genes with methylation profiles most predictive of infant weight outcomes, finding a total of 23 relevant genes in cord blood and 10 in placenta. Notably, in cord blood, the methylation profiles of three genes (PLIN4, UBE2F, and PPP1R16B) were associated with all three weight outcomes, which are also associated with weight outcomes in an independent cohort suggesting a strong relationship with weight trajectories in the first six months after birth. Additionally, we developed a Methylation Risk Score (MRS) that could be used to identify children most at risk for developing childhood obesity. While many of the genes identified by our analysis have been associated with weight-related traits (e.g., glucose metabolism, BMI, or hip-to-waist ratio) in previous genome-wide association and variant studies, our analysis implicated several others, whose involvement in the obesity phenotype should be evaluated in future functional investigations.
Recent advances in genetic and epigenetic research have underscored the significance of 5-hydroxymethylcytosine (5hmC) in neurodevelopmental disorders (NDDs), such as autism spectrum disorder (ASD) and intellectual disability (ID), revealing its potential as both a biomarker for early detection and a target for novel therapeutic strategies. This review article provides a comprehensive analysis of the role of 5hmC in NDDs by examining both animal models and human studies. By examining mouse models, studies have demonstrated that prenatal environmental challenges, such as maternal infection and food allergies, lead to significant epigenetic alterations in 5hmC levels, which were associated with NDDs in offspring, impacting social behavior, cognitive abilities and increasing ASD-like symptoms. In human studies, researchers have linked alterations in 5hmC levels NDDs through studies in individuals with ASD, fragile X syndrome, TET3 deficiency and ID, specifically identifying significant epigenetic modifications in genes such as GAD1, RELN, FMR1 and EN-2, suggesting that dysregulation of 5hmC played a critical role in the pathogenesis of these disorders and highlighted the potential for targeted therapeutic interventions. Moreover, we explore the implications of these findings for the development of epigenetic therapies aimed at modulating 5hmC levels. The review concludes with a discussion on future directions for research in this field, such as machine learning, emphasizing the need for further studies to elucidate the complex mechanisms underlying NDDs and to translate these findings into clinical practice. This paper not only advances our understanding of the epigenetic landscape of NDDs but also opens up new avenues for diagnosis and treatment, offering hope for individuals affected by these conditions.
Epigenetic modifications, such as DNA methylation, are enzymatically regulated processes that directly impact gene expression patterns. In early life, they are central to developmental programming and have also been implicated in regulating inflammatory responses. Research into the role of epigenetics in neonatal health is limited, but there is a growing body of literature related to the role of DNA methylation patterns and diseases of prematurity, such as the intestinal disease necrotizing enterocolitis (NEC). NEC is a severe intestinal inflammatory disease, but the key factors that precede disease development remain to be determined. This knowledge gap has led to a failure to design effective targeted therapies and identify specific biomarkers of disease. Recent literature has identified altered DNA methylation patterns in the stool and intestinal tissue of neonates with NEC. These findings provide the foundation for a new avenue in NEC research. In this review, we will provide a general overview of DNA methylation and then specifically discuss the recent literature related to methylation patterns in neonates with NEC. We will also discuss how DNA methylation is used as a biomarker for other disease states and how, with further research, methylation patterns may serve as potential biomarkers for NEC.
Edited by
Jeremy Koster, Max Planck Institute for Evolutionary Anthropology, Leipzig,Brooke Scelza, University of California, Los Angeles,Mary K. Shenk, Pennsylvania State University
Human behavioral ecology traditionally examines ultimate questions while “black boxing” physiological mechanisms and modes of inheritance. This chapter addresses how the intersection between human biology and behavioral ecology allows researchers to open these black boxes and how an examination of mechanisms can help to answer ultimate questions. First, the chapter discusses how physiological systems are intertwined with behavioral ones through chemical messengers, such as hormones, which broadcast information throughout the organism and coordinate actions inside the body with those outside the body. Next, the chapter looks inside the “black box of inheritance” to consider how mechanisms of inheritance beyond genes and culture, such as epigenetic inheritance, are relevant for behavioral ecology. The chapter concludes by discussing how studies of biology and behavioral ecology can complement and inform one another, leading to general insights that would be missed if both biology and behavior had not been considered in concert.
This chapter delves into the age-old nature versus nurture debate, exploring the factors that mold our individuality. As Margaret Mead observed, our distinctiveness arises from a blend of life experiences and inherent traits. Even identical twins exhibit subtle distinctions. We scrutinize whether our abilities stem from innate brain maturation or learned experiences, with nativists and empiricists offering opposing perspectives. The chapter introduces two key concepts for understanding human development. First, we explore genes – their nature, role in development, and contribution to human diversity. We delve into the intricate mechanisms governing gene expression, including the impact of epigenetics. Second, we examine how the mature brain evolves from prenatal origins, shaped by genetics and epigenetics. We challenge the notion that genes alone dictate our identities, emphasizing the dynamic interplay between genes and the environment. We avoid the term innate, recognizing the remarkable adaptability of the human brain–gene system. Our aim is to embrace the intricate interplay of genetics and environment, unveiling the path from genotype to phenotype – the observable expression of our genetic makeup.